Sandeep Chidambar Kulkarni, CEO at Tourmaline Bio, Inc. (TRML), bought 1,779 shares at $14.85 ($26K) on 2024-08-21, disclosed to the SEC on 2024-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TRML | BUY | 2023-10-26 | $111K | — | Filing → |